Altered mitochondrial function in insulin-deficient and insulin-resistant states
Open accessThe DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index; 46 of the 161 sources its claims cite were checked for support.
Abstract
Diabetes profoundly alters fuel metabolism; both insulin deficiency and insulin resistance are characterized by inefficient mitochondrial coupling and excessive production of reactive oxygen species (ROS) despite their association with normal to high oxygen consumption. Altered mitochondrial function in diabetes can be traced to insulin's pivotal role in maintaining mitochondrial proteome abundance and quality by enhancing mitochondrial biogenesis and preventing proteome damage and degradation, respectively. Although insulin enhances gene transcription, it also induces decreases in amino acids. Thus, if amino acid depletion is not corrected, increased transcription will not result in enhanced translation of transcripts to proteins. Mitochondrial biology varies among tissues, and although most studies in humans are performed in skeletal muscle, abnormalities have been reported in multiple organs in preclinical models of diabetes. Nutrient excess, especially fat excess, alters mitochondrial physiology by driving excess ROS emission that impairs insulin action. Excessive ROS irreversibly damages DNA and proteome with adverse effects on cellular functions. In insulin-resistant people, aerobic exercise stimulates both mitochondrial biogenesis and efficiency concurrent with enhancement of insulin action. This Review discusses the association between both insulin-deficient and insulin-resistant diabetes and alterations in mitochondrial proteome homeostasis and function that adversely affect cellular functions, likely contributing to many diabetic complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
30 Valid · 9 Not valid · 77 Not checked · 48 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Studies in mice support mitophagy's beneficial effect in maintaining mitochondrial quality and insulin sensitivity (101, 102).”
What the sources say
- Supportedcites [101] matched to “HSP72 Is a Mitochondrial Stress Sensor Critical for Parkin Action, Oxidative Metabolism, and Insulin Sensitivity in Skeletal Muscle” (2014) source
The Introduction (page unavailable) reports that HSP72-knockout mice had skeletal-muscle insulin resistance and links diminished HSP72 and Parkin activity to impaired mitochondrial function. The Discussion (page unavailable) interprets the retained dysfunctional mitochondria as consistent with impaired mitophagy. Together, these findings support the citing sentence’s cautious claim, though the paper presents impaired mitophagy as an interpretation rather than a direct measurement. (LLM, conf=0.88)
- Disputedcites [102] matched to “Activating HSP72 in Rodent Skeletal Muscle Increases Mitochondrial Number and Oxidative Capacity and Decreases Insulin Resistance” (2014) sourceExperimental — accuracy not yet measured
The Results (page unavailable) report that mitophagy markers did not differ significantly between HSP72-overexpressing and control mice and conclude that mitophagy did not appear markedly affected. Although the Discussion reports improved mitochondrial measures and protection against insulin resistance, this study does not show that those benefits resulted from mitophagy. (LLM, conf=0.83)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“as mTOR (17,18) and FOXO1 (19,20) control mitochondrial oxidative function via regulation of PPARγ coactivator 1α (PGC1A).”
What the sources say
- Not checked yetcites [17] Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature. 2007;450(7170):736-740. source
- Partly supportedcites [18] Schieke SM, et al. The mammalian target of rapa- mycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem. 2006;281(37):27643-27652. sourceExperimental — accuracy not yet measured
The paper reports that mTOR regulates mitochondrial oxygen consumption and oxidative capacity (Abstract) and describes an mTOR–raptor pathway affecting mitochondrial function (Discussion, p. 27649). It does not establish that this regulation occurs through PGC1A. The FOXO1 portion is attached to other citations, not this source. (LLM, conf=0.87)
- Supportedcites [19] Cheng Z, et al. Foxo1 integrates insulin signaling with mitochondrial function in the liver. Nat Med. 2009;15(11):1307-1311. source
The cited paper supports the FOXO1 portion of the sentence, not the separately cited mTOR portion. Its discussion of hepatic insulin resistance says sustained Foxo1 activity indirectly inactivates Ppargc-1α through acetylation, impairing mitochondrial biogenesis and function; deleting Foxo1 reduces that acetylation and restores mitochondrial function. (LLM, conf=0.91)
- Not checked yetcites [20] Daitoku H, Yamagata K, Matsuzaki H, Hatta M, Fukamizu A. Regulation of PGC-1 pro- moter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes. 2003;52(3):642-649. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Similarly, mRNA levels of transcriptional regulators of mitochondrial mass and function (e.g., Pgc1a, Pgc1b, Tfam) were downregulated in Akita mouse hearts (59).”
What the sources say
- Supportedcites [59] Bugger H, et al. Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice. Diabetes. 2009;58(9):1986-1997. source
The Discussion reports coordinate repression of PGC-1α, PGC-1β, and TFAm—among the transcriptional regulators of mitochondrial mass and function—in Akita hearts. This directly supports the cited claim about their mRNA levels. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Studies in rodents have concluded that the brain may be spared from alterations to mitochondrial morphology and function in T1D (59,68,69).”
What the sources say
- Supportedcites [59] Bugger H, et al. Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice. Diabetes. 2009;58(9):1986-1997. source
The Results (Tissue ultrastructure; page not provided) report no difference in brain mitochondrial morphology between diabetic Akita and wild-type mice. The Abstract (Conclusions) states that brain mitochondrial function was preserved, and the Discussion cautions that dysfunction after a longer duration of diabetes cannot be ruled out. This supports the citing sentence’s hedged claim. (LLM, conf=0.91)
- Not checked yetcites [68] Moreira PI, Santos MS, Moreno AM, Proença T, Seiça R, Oliveira CR. Effect of streptozotocin- induced diabetes on rat brain mitochondria. J Neuroendocrinol. 2004;16(1):32-38. source
- Partly supportedcites [69] Santos RX, et al. Insulin therapy modulates mito- chondrial dynamics and biogenesis, autophagy jci.org Volume 128 Number 9 September 2018 and tau protein phosphorylation in the brain of type 1 diabetic rats. Biochim Biophys Acta. 2014;1842(7):1154-1166. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports no alteration of mitochondrial function in the cerebral cortex of T1D rats, supporting the functional part of the claim. But it also describes a pattern compatible with enhanced mitochondrial fragmentation, so the paper does not support saying the brain is spared from alterations to mitochondrial morphology. (LLM, conf=0.90)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Various rodent models of T1D display impairments in kidney mitochondrial functions, such as increased basal membrane expenditure; these were also elevated in comparison with predicted energy values for non-T1D people of similar age and body composition (4, 49).”
What the sources say
- Partly supportedcites [4] Nair KS, Halliday D, Garrow JS. Increased energy expenditure in poorly controlled Type 1 (insulin- dependent) diabetic patients. Diabetologia. 1984;27(1):13-16. sourceExperimental — accuracy not yet measured
The Abstract and Results report that basal energy expenditure in ten people with poorly controlled Type 1 diabetes exceeded values predicted from age, sex, and body surface area. The paper does not establish kidney mitochondrial impairment in rodent models, and its predicted values are not described as matched for body composition. (LLM, conf=0.88)
- Not checked yetcites [49] Charlton MR, Nair KS. Role of hypergluca- gonemia in catabolism associated with type 1 diabetes: effects on leucine metabolism and the resting metabolic rate. Diabetes. 1998;47(11):1748-1756. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
56 more claims · 8 with their cited sources checked
Create a free account to see all 164 claims and to verify the 115 references still open.
- It may state two separate claims as one. 89
- Probably not a substantial claim. 26
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mice, the deletion of mTORC1 leads to high muscle atrophy, and in humans, the daily ingestion of 10 g of essential amino acids induces a 60% increase in muscle protein synthesis levels that is absent when mTORC1 inhibitors are simultaneously administered, confirming that mTORC1 is a key regulator of protein synthesis (24, 25).”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Introduction
“Insulin inhibits not only degradation of endogenous proteins but also fat storage.”
§ Insulin regulates mitochondrial biogenesis, degradation, and function
“promoting lipid synthesis and storage in liver and AT”
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · cited 1×
“Additional studies confirmed that mitochondrial content is decreased and many factors regulating mitochondria are altered in obese, insulin-resistant adults as well as the offspring of parents with T2D (33, 78–82).”
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Sequence and organization of the human mitochondrial genome
Anderson, S., Bankier, A. T., Barrell, B. G., de Bruijn, M. H. L., Coulson, A. R., Drouin, J., Eperon, I. C., Nierlich, D. P., Roe, B. A., Sanger, F., et al. (1981) · Nature · doi:10.1038/290457a0 · Cited by 9,636
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 1×
“Given that 80% of AD patients display impaired glucose tolerance or T2D (44), and the AD brain displays insulin resistance and impaired mitochondrial function (45, 46), strategies that enhance insulin sensitivity in diabetes may also have therapeutic value in AD.”
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Identification and Importance of Brown Adipose Tissue in Adult Humans
Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399
Exercise capacity and mortality among men referred for exercise testing
Myers, J., Prakash, M., Froelicher, V., Do, D., Partington, S., & Atwood, J. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011858 · Cited by 4,114
Mitochondria: In Sickness and in Health
Nunnari, J., & Suomalainen, A. (2012) · Cell · doi:10.1016/j.cell.2012.02.035 · Cited by 3,479
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Cited by
The integrative biology of type 2 diabetes
Roden, M., & Shulman, G. I. (2019) · Nature · doi:10.1038/s41586-019-1797-8 · Cited by 1,167
Role of Insulin in Health and Disease: An Update
Rahman, M. S., Hossain, K. S., Das, S., Kundu, S., Adegoke, E. O., Rahman, M. A., Hannan, M. A., Uddin, M. J., & Pang, M.-G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126403 · Cited by 472
Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management
Wei, S., Nguyen, T. T., Zhang, Y., Ryu, D., & Gariani, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1185221 · Cited by 291
“In mice, the deletion of mTORC1 leads to high muscle atrophy, and in humans, the daily ingestion of 10 g of essential amino acids induces a 60% increase in muscle protein synthesis levels that is absent when mTORC1 inhibitors are simultaneously administered, confirming that mTORC1 is a key regulator of protein synthes…”
BackgroundThe brain as an insulin-sensitive metabolic organ
Milstein, J. L., & Ferris, H. A. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101234 · Cited by 259
Chen, X., Xie, N., Feng, L., Huang, Y., Wu, Y., Zhu, H., Tang, J., & Zhang, Y. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003230 · Cited by 172
Astaxanthin: A Potential Mitochondrial-Targeted Antioxidant Treatment in Diseases and with Aging
Sztretye, M., Dienes, B., Gönczi, M., Czirják, T., Csernoch, L., Dux, L., Szentesi, P., & Keller-Pintér, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3849692 · Cited by 214
“Insulin resistance is characterized by inefficient mitochondrial coupling, low level of ATP, and the formation of excess amount of ROS despite the normal to high oxygen consumption [73, 75].”
BackgroundInsulin action in the brain: cell types, circuits, and diseases
Chen, W., Cai, W., Hoover, B., & Kahn, C. R. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.03.001 · Cited by 165
Causal relationship between insulin resistance and sarcopenia
Liu, Z.-J., & Zhu, C. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01022-z · Cited by 177
Xiong, Y., Knoedler, S. A., Alfertshofer, M. G., Kim, B., Jiang, D., Liu, G., Rinkevich, Y., & Mi, B. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07583-3 · Cited by 192
Mitochondria and T2D: Role of Autophagy, ER Stress, and Inflammasome
Rocha, M., Apostolova, N., Díaz‐Rúa, R., Muntané, J., & Víctor, V. M. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.03.004 · Cited by 163
Acute kidney injury and maladaptive tubular repair leading to renal fibrosis
Yu, S. M.-W., & Bonventre, J. V. (2020) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000605 · Cited by 160
Oxygenation of adipose tissue: A human perspective
Lempesis, I. G., van Meijel, R. L. J., Manolopoulos, K. N., & Goossens, G. H. (2019) · Acta Physiologica · doi:10.1111/apha.13298 · Cited by 142
Hong, C.-T., Chen, K.-Y., Wang, W., Chiu, J.-Y., Wu, D., Chao, T.-Y., Hu, C.-J., Chau, K.-Y., & Bamodu, O. (2020) · Cells · doi:10.3390/cells9030740 · Cited by 133
Astaxanthin as a Novel Mitochondrial Regulator: A New Aspect of Carotenoids, beyond Antioxidants
Nishida, Y., Nawaz, A., Hecht, K. A., & Tobe, K. (2021) · Nutrients · doi:10.3390/nu14010107 · Cited by 142
Exercise in adults with type 1 diabetes mellitus
Riddell, M. C., & Peters, A. L. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00756-6 · Cited by 145
Gabriel, B. M., Altıntaş, A., Smith, J. A. B., Puig, L. S., Zhang, X., Basse, A. L., Laker, R. C., Gao, H., Liu, Z., Dollet, L., et al. (2021) · Science Advances · doi:10.1126/sciadv.abi9654 · Cited by 128
The competitive athlete with type 1 diabetes
Riddell, M. C., Scott, S. N., Fournier, P. A., Colberg, S. R., Gallen, I. W., Moser, O., Stettler, C., Yardley, J. E., Zaharieva, D. P., Adolfsson, P., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05183-8 · Cited by 101
He, Q., Yuan, S., Tang, H., Wang, S., Mu, Z., Li, D., Wang, S., Jing, X., Hu, S., Ji, P., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202101611 · Cited by 101
Proteomics Analysis of Gastric Cancer Patients with Diabetes Mellitus
Osório, H., Silva, C., Ferreira, M., Gullo, I., Máximo, V., Barros, R., Mendonça, F., Oliveira, C., & Carneiro, F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030407 · Cited by 83
Yaribeygi, H., Maleki, M., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Diabetes Research · doi:10.1155/2021/7796727 · Cited by 91
Awonuga, A. O., Camp, O. G., & Abu‐Soud, H. M. (2023) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-023-01159-6 · Cited by 94
FoxO transcription factors in mitochondrial homeostasis
Cheng, Z. (2022) · Biochemical Journal · doi:10.1042/bcj20210777 · Cited by 89
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts
Cullinane, P. W., Pablo‐Fernández, E. D., König, A., Outeiro, T. F., Jaunmuktane, Z., & Warner, T. T. (2022) · Movement Disorders · doi:10.1002/mds.29298 · Cited by 82
Galizzi, G., & Carlo, M. D. (2022) · Biology · doi:10.3390/biology11060943 · Cited by 87
Research progress of coumarins and their derivatives in the treatment of diabetes
Pan, Y., Liu, T., Wang, X., & Sun, J. (2022) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.2024526 · Cited by 76
Integrative biology of extracellular vesicles in diabetes mellitus and diabetic complications
Liu, J., Zhang, Y., Tian, Y., Huang, W. C., Tong, N., & Fu, X. (2022) · Theranostics · doi:10.7150/thno.65778 · Cited by 78
Ding, X.-W., Robinson, M., Li, R., Aldhowayan, H., Geetha, T., & Babu, J. R. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105783 · Cited by 88
Ueda, K., Sakai, C., Ishida, T., Morita, K., Kobayashi, Y., Horikoshi, Y., Baba, A., Okazaki, Y., Yoshizumi, M., Tashiro, S., et al. (2023) · Clinical Science · doi:10.1042/cs20220525 · Cited by 79
Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome
Shan, H., Luo, R., Guo, X., Li, R., Ye, Z., Peng, T., Liu, F.-T., & Yang, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.904942 · Cited by 79
Li, A., Lian, L., Chen, X.-N., Cai, W.-H., Fan, X., Fan, Y.-J., Li, T., Xie, Y., & Zhang, J. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.08.009 · Cited by 74
Li, Y., Tang, Y., Shi, S., Gao, S., Wang, Y., Xiao, D., Chen, T., He, Q. P., Zhang, J., & Lin, Y. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c11468 · Cited by 67
The Role of PGC-1α-Mediated Mitochondrial Biogenesis in Neurons
Chen, M., Yan, R., Luo, J.-S., Ning, J., Zhou, R., & Ding, L. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03934-8 · Cited by 66
Hu, M., Jiang, W., Ye, C., Hu, T., Yu, Q., Moran, M., Sun, L., Liang, J., & Chen, Y. (2023) · Phytotherapy Research · doi:10.1002/ptr.7984 · Cited by 63
Ruegsegger, G. N., Manjunatha, S., Summer, P., Gopala, S., Zabeilski, P., Dasari, S., Vanderboom, P. M., Lanza, I. R., Klaus, K. A., & Nair, K. S. (2019) · The FASEB Journal · doi:10.1096/fj.201802043r · Cited by 60
Self-citationBhardwaj, G., Penniman, C. M., Jena, J., Beltran, P. A. S., FOSTER, C. M., Poro, K., Junck, T. L., Hinton, A. O., Jr., Souvenir, R., Fuqua, J. D., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146415 · Cited by 61
Brain insulin resistance and cognitive function: influence of exercise
Malin, S. K., Stewart, N. R., Ude, A. A., & Alderman, B. L. (2022) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00375.2022 · Cited by 56
Mitochondrial Dysfunction and Diabetes: Is Mitochondrial Transfer a Friend or Foe?
Montgomery, M. K. (2019) · Biology · doi:10.3390/biology8020033 · Cited by 66
The Role of Mitochondrial Quality Control in Cognitive Dysfunction in Diabetes
Luo, J.-S., Ning, J., Chen, Z.-Y., Li, W., Zhou, R., Yan, R., Chen, M., & Ding, L.-L. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03631-y · Cited by 56
Metabolic Regulation of Mitochondrial Protein Biogenesis from a Neuronal Perspective
Hees, J. T., & Harbauer, A. B. (2022) · Biomolecules · doi:10.3390/biom12111595 · Cited by 57
Huang, J., Zhao, J., Geng, X., Chu, W., Li, S., Chen, Z., & Du, Y. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.12.008 · Cited by 55
Juère, E., Caillard, R., Marko, D., Favero, G. D., & Kleitz, F. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202000773 · Cited by 49
Sun, W., Kou, X., Wu, C., Fan, G., Li, T., Cheng, X., Xu, K., Suo, A., & Tao, Z. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124301 · Cited by 48
Moore, T. M., Cheng, L., Wolf, D. M., Ngo, J., Segawa, M., Zhu, X., Strumwasser, A. R., Cao, Y., Clifford, B. L., Ma, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34468-2 · Cited by 54
Vaccine Therapy for Heart Failure Targeting the Inflammatory Cytokine Igfbp7
Katoh, M., Nomura, S., Yamada, S., Ito, M., Hayashi, H., Katagiri, M., Heryed, T., Fujiwara, T., Takeda, N., Nishida, M., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.064719 · Cited by 49
Chen, Y., Yang, F., Chu, Y., Yun, Z., Yan, Y., & Jin, J. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03693-0 · Cited by 46
Effects of (−)-epicatechin on mitochondria
Daussin, F., Heyman, E., & Burelle, Y. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa094 · Cited by 46
Ruegsegger, G. N., Pataky, M. W., Simha, S., Robinson, M. M., Klaus, K. A., & Nair, K. S. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00405.2023 · Cited by 38
Self-citationSaedi, S., Watson, S. E., Young, J. L., Tan, Y., Wintergerst, K. A., & Cai, L. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121385 · Cited by 39
YY1 deficiency in β-cells leads to mitochondrial dysfunction and diabetes in mice
Song, D., Yang, Q., Jiang, X., Shan, A., Nan, J., Lei, Y., Ji, H., Wei, D., Yang, T., Wang, T., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154353 · Cited by 38
Franzke, B., Schwingshackl, L., & Wagner, K. (2020) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2020.108343 · Cited by 41
Bird evolution by insulin resistance
Satoh, T. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.07.007 · Cited by 39
Dial, A. G., Monaco, C. M. F., Grafham, G. K., Patel, T. P., Tarnopolsky, M. A., & Hawke, T. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab261 · Cited by 42
Yu, P., Chen, L. Y., Chen, Y., Thomas, E. R., Zhou, S., Yang, Y., Liu, K., Wu, J., & Li, X. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1625474 · Cited by 39
Altered intramuscular network of lipid droplets and mitochondria in type 2 diabetes
de Almeida, M. E., Nielsen, J., Petersen, M. H., Wentorf, E. K., Pedersen, N. B., Jensen, K., Højlund, K., & Ørtenblad, N. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00470.2022 · Cited by 38
Liu, J., Wu, X., Deng, X., Zhu, H., Wang, T., Wang, M., Yang, S., Xu, J., Chen, Q., Li, M., et al. (2022) · Cells · doi:10.3390/cells11244091 · Cited by 35
Metformin May Contribute to Inter-individual Variability for Glycemic Responses to Exercise
Malin, S. K., & Stewart, N. R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00519 · Cited by 34
Mitochondrial Regulation of Diabetic Kidney Disease
Galvan, D. L., Mise, K., & Danesh, F. R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.745279 · Cited by 42
The phospholipase A2 family’s role in metabolic diseases: Focus on skeletal muscle
Cervera, I. P., Gabriel, B. M., Aldiss, P., & Morton, N. M. (2021) · Physiological Reports · doi:10.14814/phy2.14662 · Cited by 35
Ye, W., Han, K., Xie, M., Li, S., Chen, G., Wang, Y., & Li, T. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003075 · Cited by 36
Targeting mitochondrial transporters and metabolic reprogramming for disease treatment
Anselme, M., He, H., Lai, C., Luo, W., & Zhong, S. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06976-4 · Cited by 37
Jackson, T. W., Ryherd, G. L., Scheibly, C. M., Sasser, A. L., Guillette, T. C., & Belcher, S. M. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa154 · Cited by 31
GRP75 Regulates Mitochondrial-Supercomplex Turnover to Modulate Insulin Sensitivity
Zhao, Q., Luo, T., Gao, F., Fu, Y., Li, B., Shao, X., Chen, H., Zhou, Z., Guo, S., Shen, L., et al. (2021) · Diabetes · doi:10.2337/db21-0173 · Cited by 31
YY1 Regulates Glucose Homeostasis Through Controlling Insulin Transcription in Pancreatic β-Cells
Liu, D., Yang, Y., Chan, V. W., Ye, W.-C., Chong, C. C. N., Wang, C. C., Wang, H., Zhou, B., Cheng, K. K. Y., & Lui, K. O. (2022) · Diabetes · doi:10.2337/db21-0695 · Cited by 30
Drug-induced mitochondrial toxicity: Risks of developing glucose handling impairments
Kuretu, A., Arineitwe, C., Mothibe, M. E., Ngubane, P. S., Khathi, A., & Sibiya, N. H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1123928 · Cited by 34
Galizzi, G., Palumbo, L., Amato, A., Conigliaro, A., Nuzzo, D., Terzo, S., Caruana, L., Picone, P., Alessandro, R., Mulè, F., et al. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.08.014 · Cited by 28
Calcium signalling in hepatic metabolism: Health and diseases
Humbert, A., Lefebvre, R., Nawrot, M., Caussy, C., & Rieusset, J. (2023) · Cell Calcium · doi:10.1016/j.ceca.2023.102780 · Cited by 30
Penniman, C. M., Beltran, P. A. S., Bhardwaj, G., Junck, T. L., Jena, J., Poro, K., Hirshman, M. F., Goodyear, L. J., & O'Neill, B. T. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.001 · Cited by 30
Xiao, M., Yang, H. J., Dong, M., Mao, X., Pan, H., Lei, Y., Tong, X., Yu, X., Yu, X., & Shi, S. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06984-0 · Cited by 31
Reduced glucose tolerance and insulin sensitivity after prolonged exercise in endurance athletes
Flockhart, M., Tischer, D., Nilsson, L. C., Blackwood, S. J., Ekblom, B. T., Katz, A., Apró, W., & Larsen, F. J. (2023) · Acta Physiologica · doi:10.1111/apha.13972 · Cited by 30
Ratan, Y., Rajput, A., Pareek, A., Pareek, A., Kaur, R., Sonia, S., Kumar, R., & Singh, G. (2024) · Biomedicines · doi:10.3390/biomedicines12071390 · Cited by 33
Shen, J., Wang, X., Wang, M., & Zhang, H. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1337442 · Cited by 31
Melis, M. J., Khpal, M., Peters, V. B. M., & Singer, M. (2023) · Clinical Science · doi:10.1042/cs20220709 · Cited by 27
de Almeida, M. E., Ørtenblad, N., Petersen, M. H., Schjerning, A., Wentorf, E. K., Jensen, K., Højlund, K., & Nielsen, J. (2023) · The Journal of Physiology · doi:10.1113/jp284386 · Cited by 25
James, H. A., Gonsalves, W. I., Manjunatha, S., Dasari, S., Lanza, I. R., Klaus, K. A., Vella, A. V., Andrews, J. C., & Nair, K. S. (2022) · Diabetes · doi:10.2337/db22-0079 · Cited by 23
Self-citationSkeletal muscle performance in metabolic disease: Microvascular or mitochondrial limitation or both?
Frisbee, J. C., Lewis, M. T., & Wiseman, R. W. (2018) · Microcirculation · doi:10.1111/micc.12517 · Cited by 24
Lian, K., Wang, Q. L., Zhao, S., Yang, M., Chen, G., Chen, Y., Li, C., Gao, H., & Li, C. (2019) · Cell Transplantation · doi:10.1177/0963689719885076 · Cited by 23
Prabhakaran, P., Justin, A., Kumar, T. D. A., Chinaswamy, M., & Kumar, B. R. P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00085 · Cited by 25
Shi, M., Li, X., Xing, L., Li, Z., Zhou, S., Wang, Z., Zou, X., She, Y., Zhao, R., & Qin, D. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121556 · Cited by 26
Luckhart, S., & Riehle, M. A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.593159 · Cited by 25
Obesity, Body Image Dissatisfaction, and Sexual Dysfunction: A Narrative Review
McNabney, S. M. (2022) · Sexes · doi:10.3390/sexes3010002 · Cited by 28
Mazibuko-Mbeje, S. E., Mthembu, S. X. H., Dludla, P. V., Madoroba, E., Chellan, N., Kappo, A. P., & Muller, C. J. F. (2021) · Toxicology in Vitro · doi:10.1016/j.tiv.2021.105224 · Cited by 24
Mthembu, S. X. H., Muller, C. J. F., Dludla, P. V., Madoroba, E., Kappo, A. P., & Mazibuko-Mbeje, S. E. (2021) · Molecules · doi:10.3390/molecules26206289 · Cited by 24
Li, X., Yang, Y., Shi, X., Zhang, Z., & Ding, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063196 · Cited by 23
Bjune, M. S., Lindquist, C., Stafsnes, M. H., Bjørndal, B., Bruheim, P., Aloysius, T. A., Nygard, O. K., Skorve, J., Madsen, L., Dankel, S. N., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158887 · Cited by 23
Iron overload in hypothalamic AgRP neurons contributes to obesity and related metabolic disorders
Zhang, Y., Chen, L., Ye, X., Zhang, L., Tian, W., Zhu, Y., Wang, J., Wang, X., Qiu, J., Yu, J. L., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113900 · Cited by 26
Peanut leaf extract has antioxidant and anti-inflammatory activity but no acute toxic effects
Cossetin, J. F., Brum, E. D. S., Casoti, R., Camponogara, C., Dornelles, R. C., Maziero, M., Antoniazzi, C. T. D. D., Guex, C. G., Ramos, A. P., Pintos, F. G., et al. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.104407 · Cited by 22
Bhardwaj, G., Penniman, C. M., Klaus, K. A., Weatherford, E. T., Pan, H., Dreyfuss, J. M., Nair, K. S., Kahn, C. R., & O'Neill, B. T. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.779121 · Cited by 22
Self-citationYu, P., Liu, B., Dong, C., & Chang, Y. (2025) · Cells · doi:10.3390/cells14080619 · Cited by 20
Implications of the cGAS-STING pathway in diabetes: Risk factors and therapeutic strategies
Mohammadi, S., & Khorasani, M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134210 · Cited by 22
Yuan, D., Li, H., Dai, W., Zhou, X., Zhou, W., & He, L. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167022 · Cited by 19
Therapeutics for mitochondrial dysfunction-linked diseases in Down syndrome
Ganguly, B. B., & Kadam, N. N. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.11.003 · Cited by 18
Vera, D. M., Zambrana-Infantes, E. N., López-Gambero, A. J., Verheul-Campos, J., Santín, L. J., Baixerás, E., Suárez, J., Pavón, F. J., Rosell‐Valle, C., & de Fonseca, F. R. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106295 · Cited by 18
Zhao, M., Qin, J., Shen, W., & Wu, A. (2021) · BioMed Research International · doi:10.1155/2021/8835408 · Cited by 18
Untangling the genetic link between type 1 and type 2 diabetes using functional genomics
Nyaga, D. M., Vickers, M. H., Jefferies, C., Fadason, T., & O'Sullivan, J. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-93346-x · Cited by 18
Mann, G., Riddell, M. C., & Adegoke, O. A. J. (2022) · Diabetology · doi:10.3390/diabetology3030032 · Cited by 20
Therapeutic potential of natural coumarins in autoimmune diseases with underlying mechanisms
Li, Y., Wang, G., & Li, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1432846 · Cited by 22
Zhu, W., Zhou, Z., Sun, J., & Si, J. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1671926 · Cited by 15
The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology
Ribarič, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084358 · Cited by 18
The risk factors of type 2 diabetes in hypertensive subjects
Chen, Y., Ma, J., Lu, D., & Fang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.901614 · Cited by 14
Chen, S., WU, S. M., & Lin, B. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1417672 · Cited by 20
Metadata
- Authors
- Ruegsegger, G. N., Creo, A. L., Cortes, T. M., Dasari, S., & Nair, K. S.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Nair, K. Sreekumaran
- Venue
- Journal of Clinical Investigation
- Published
- 2018-08-31
- Volume
- 128
- Issue
- 9
- Pages
- 3671-3681
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC6118582
- OpenAlex
- W2889183927
- Cited by
- 202
- References
- 154
- Citations by year
- 2026: 15 · 2025: 32 · 2024: 33 · 2023: 28 · 2022: 32 · 2021: 34 · 2020: 17 · 2019: 10 · 2018: 1
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (T32AG049672)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK101402, U24DK100469)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- mitochondrial function, insulin deficiency, insulin resistance, diabetes mellitus, mitochondrial biogenesis, reactive oxygen species, mitochondrial proteome, oxidative stress, amino acid starvation, skeletal muscle, aerobic exercise, mitochondrial coupling, diabetes complications
- MeSH terms
- Amino Acids, Animals, Diabetes Mellitus, DNA Damage, Female, Humans, Insulin, Insulin Resistance, Male, Mitochondria, Mitochondria, Liver, Mitochondria, Muscle, Models, Biological, Oxygen Consumption, Signal Transduction, Reactive Oxygen Species, Proteome, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.